Eli Lilly appoints Lucas Montarce as CFO in September 2024
- Lucas Montarce has been appointed as the new executive vice president and CFO of Eli Lilly, effective immediately.
- He has held various finance leadership roles within the company since joining in 2001, including his most recent position as president and general manager for the Spain, Portugal, and Greece hub.
- Montarce aims to build on Lilly's financial foundation and drive continued success as the company expands globally.
On September 9, 2024, Eli Lilly and Company announced the appointment of Lucas Montarce as its new executive vice president and chief financial officer (CFO). Montarce, who has been with Lilly since 2001, has held various finance leadership roles, including positions as group vice president and corporate controller. His most recent role was as president and general manager for the Spain, Portugal, and Greece hub. David A. Ricks, the chair and CEO of Lilly, expressed excitement about Montarce's appointment, highlighting his extensive experience and leadership capabilities. Ricks emphasized that Montarce's diverse background in finance and his commitment to the company would be instrumental in driving Lilly's financial strategies. Montarce holds a bachelor's degree in business accounting from Catholic University in Argentina and an MBA from the Center for Macroeconomic Studies of Argentina. He expressed his dedication to building on Lilly's strong financial foundation and contributing to the company's growth and success in the global market. Eli Lilly is focused on advancing healthcare solutions through innovative research and development. The company aims to address significant health challenges, including diabetes, obesity, Alzheimer's disease, immune system disorders, and cancer. Montarce's leadership is expected to play a crucial role in ensuring that Lilly continues to deliver value to its stakeholders while expanding its global footprint.